• 제목/요약/키워드: Residual Pharmaceuticals

검색결과 17건 처리시간 0.027초

온라인 자동화 시료 전처리 및 HR Orbitrap LC/ESI-MS를 이용한 환경시료 중 잔류 의약물질 분석방법 확립 (Establishment of the Analytical Method for Residual Pharmaceuticals in Raw Water Using Online Sample Preparation and High Resolution Orbitrap LC/ESI-MS)

  • 황윤정;신상희;박종숙
    • 한국물환경학회지
    • /
    • 제29권3호
    • /
    • pp.409-419
    • /
    • 2013
  • In this study, the analytical method for 27 residual pharmaceuticals in raw water was developed. Online sample preconcentration/extraction and analysis with high resolution Orbitrap mass spectrometry (LC-ESI/Orbitrap MS) were performed. The calibration curves showed good linearities (above $r^2$ = 0.998) in the range of 5 ~ 1,000 ng/L. The method detection limit and the limit of quantification were 1.1 ~ 10.0 ng/L and 3.4 ~ 31.7 ng/L, respectively. Recoveries of the target compounds were between 70.1% and 115.8% (except cefadroxil, cefradine, vancomycin, and iopromide (50.2 ~ 67.0%)). The optimized analytical method can be useful to determine the residual pharmaceuticals in raw water.

LC/ESI-MS/MS를 이용한 하천수 중 잔류 6종 의약물질의 동시분석 및 모니터링 (Simultaneous analysis and occurrences of six pharmaceuticals in surface water by LC/ESI-MS/MS)

  • 김병주;명승운
    • 분석과학
    • /
    • 제23권6호
    • /
    • pp.572-578
    • /
    • 2010
  • 본 연구에서는 하천수 중 6종의 의약물질(cephradine, cefadroxil, penicillin G, vancomycin, iopromide, and fenbendazole)에 대한 전처리법과 분석 방법을 확립하였다. 하천수 중의 분석물질을 HLB(Hydrophilic-Lipophilic Balanced) 카트리지를 사용하여 추출/정제 및 농축하였다. HPLC/ESI-MS/MS를 이용하여 6종의 물질들을 동시에 분석하였다. Fenbendazole을 제외한 의약물질은 71.1~92.6% 범위의 양호한 회수율을 나타내었고, 상대표준편차는 11.2% 이하로 나타났다. 정량분석을 위해서 0.007~1.2 ng/mL 범위에서 $r^2$=0.99 이상의 높은 직선성을 나타내는 검량선을 얻었다. 검출한계(LOD)와 정량한계(LOQ)는 각각 7.2~128.7 pg/mL, 23.8~429.1 pg/mL로 나타났다. 이 분석 방법은 하천수 중 의약품에 대한 모니터링에 유용하며, 하천수 중 iopromide과 fenbendazole은 높은 농도로 검출되었다.

하수처리시설 단위공정별 잔류의약물질 거동 및 물질수지 분석 (Fate and mass balance of pharmaceuticals of unit processes in a sewage treatment plant)

  • 박준원;김창수;이원석;이수형;정현미;정동환
    • 상하수도학회지
    • /
    • 제33권5호
    • /
    • pp.367-377
    • /
    • 2019
  • In this study, the fate and removal of 15 pharmaceuticals (including stimulants, non-steroidal anti-inflammatory drugs, antibiotics, etc.) in unit processes of a sewage treatment plant (STP) were investigated. Mass loads of pharmaceuticals were 2,598 g/d in the influent, 2,745 g/d in the primary effluent, 143 g/d in the secondary effluent, and 134 g/d in the effluent. The mass loads were reduced by 95% in the biological treatment process, but total phosphorous treatment did not show a significant effect on the removal of most pharmaceuticals. Also, mass balance analysis was performed to evaluate removal characteristics of pharmaceuticals in the biological treatment process. Acetaminophen, caffeine, acetylsalicylic acid, cefradine, and naproxen were efficiently removed in the biological treatment process mainly due to biodegradation. Removal efficiencies of gemfibrozil, ofloxacin, and ciprofloxacin were not high, but their removal was related to sorption onto sludge. This study provides useful information on understanding removal characteristics of pharmaceuticals in unit processes in the STP.

상수원에서의 잔류 의약물질 검출, 거동, 분포 현황 및 독성 (Occurrence of Residual Pharmaceuticals and Fate, Residue and Toxic Effect in Drinking Water Resources)

  • 손희종;장성호
    • 대한환경공학회지
    • /
    • 제33권6호
    • /
    • pp.453-479
    • /
    • 2011
  • 오늘날 전세계적으로 수환경에서의 잔류 의약물질들의 오염에 대한 연구결과들이 많이 보고되고 있다. 이들 잔류 의약물질들은 다양한 종류와 그들이 가지는 물리 화학적인 특성들로 인해 수환경에서의 거동, 오염현황, 영향 및 독성 등도 매우 다양하여 수환경 및 수처리 공정에서의 거동을 예측 평가하기가 어렵다. 선진 외국의 경우 환경 중에서의 오염 현황 및 사용량을 정량화하기 위한 조사를 이미 시작하였고, 잔류 의약물질들의 인체에 대한 잠재적 위험성뿐만 아니라 상수나 하수처리 공정에서의 제거기술에 관한 다양한 연구도 활발히 진행하고 있다. 그러나 국내의 경우 잔류 의약물질들에 대해 전국 주요하천과 상수원에 대한 모니터링 결과도 매우 부족한 실정이다. 우선 국내의 경우는 상수원으로 이용되는 전국 주요 하천과 호소에 대해 주기적이고 체계적인 오염현황 평가가 선행되어야 하며, 잔류 의약물질들이 비교적 고농도로 검출되는 상수원에 대해서는 주오염원에 대한 조사도 병행되어야 한다. 또한, 의약물질 사용량은 지속적으로 증가할 것으로 전망되기 때문에 하수처리 시설에 대한 부하도 지속적으로 증가할 것이다. 따라서 수환경에서의 유해도를 저감시키기 위해 효과적인 하수처리 공법의 도입이 절실하며, 상수에 대한 안전성 확보를 위해서도 잔류 의약물질들의 수환경중에서의 물리 화학적 거동에 대한 면밀한 연구가 요구된다.

제약단지 인접 지역 지표수의 잔류 의약물질 생태위해성평가 (Ecological Risk Assessment of Pharmaceuticals in the Surface Water Near a Pharmaceutical Manufacturing Complex in Korea)

  • 박수현;강하병;신혜수;유일한;최경호;고영림;박경화;김경태;지경희
    • 한국환경보건학회지
    • /
    • 제46권1호
    • /
    • pp.45-64
    • /
    • 2020
  • Objectives: Limited information is available on the presence and associated ecological risks of pharmaceutical residues in aquatic environments near pharmaceutical manufacturing areas in Korea. In this study, we investigated the current state of pharmaceutical contamination and its associated ecological risks in streams near a pharmaceutical manufacturing complex. Methods: Seven pharmaceuticals (acetaminophen, clarithromycin, diclofenac, diphenhydramine, ibuprofen, mefenamic acid and roxithromycin) were measured in water samples collected from the streams near a pharmaceutical manufacturing complex. A predicted no-effect concentration (PNEC) was derived using either the assessment factor method or species sensitivity distribution method. In addition, a hazard quotient for each pharmaceutical was calculated by dividing its measured environmental concentration by its PNEC. Results: Samples collected downstream from the wastewater treatment plant (WWTP) had higher concentrations of pharmaceuticals than those collected from the reference site (upstream). Moreover, pharmaceutical concentrations were greater in ambient water than in the final effluent from the WWTP, which suggested that non-point sources were contributing to the contamination of the ambient water environment. Some of the target pharmaceuticals exhibited a hazard quotient >1, indicating that their potential ecological effects on the aquatic environment near the pharmaceutical industrial area should not be ignored. Conclusion: This study demonstrated that the pharmaceutical manufacturing area was contaminated with residual drugs, and that there was a possible non-point source near the WWTP effluent discharge area. The results of this study will aid in the development of management plans for pharmaceuticals, particularly in hotspots such as pharmaceutical industrial sites and their vicinities.

Preliminary Risk Assessment of Several Major Pharmaceutical Products In Aquatic Ecosystem

  • Park, Su-Jung;Oh, So-Rin;Jung, Jin-Yong;Kim, Young-Hee;Kim, Pan-Gyi;Choi, Kyung-Ho
    • 한국환경보건학회:학술대회논문집
    • /
    • 한국환경보건학회 2005년도 국제학술대회
    • /
    • pp.345-350
    • /
    • 2005
  • Acute toxicities of five pharmaceutical products were evaluated with aquatic microbes, invertebrates, and fish. The test pharmaceuticals, i.e., cimetidine, carbamazepine, diltiazem, acetaminophene, and metformin have been often detected in aquatic environment, but theire cological hazard on receptors of various trophic levels has seldom been evaluated. In the present study, we conducted acute toxicity assays with a marine bacterium, Vibrio fischeri, an invertebrate, Daphnia magna, and a fish, Japanese medake (Oryzias latipes). In general, D. magna, showed the most sensitive response to the test chemicals. Diltiazem exhibited the lowest EC50 value after 96 hr of exposure at 7.6 mg/L, followed by cimetidine >acetaminophen > metformin = carbamazepine in an order of decreasing susceptibility. With the fish, diltiazem and carbamazepine showed the 96 hr EC50 values at 14.1${\sim}$35.4 mg/L while acetaminophen, cimetidine, and metformin did not cause 50% mortality at 100 mg/L. Similar pattern was noted with the Microtox Assay, with which the median effective concentrations for acetaminophen, cimetidine, and metformin were found at the range between 301.8 and 755.4 mg/L. Carbamazepine and diltiazem exposure to the microbes resulted in EC50 values around 50 mg/L. Predicted no effect concentrations (PECs) of these pharmaceuticals derived from the EC5O values obtained from this study, and predicted environmental concentrations (PECs) obtained from available literatures were utilized to estimate ecological risks of the test compounds. No test pharmaceuticals resulted in risk quotients (PEC/PNEC) greater than 1, which suggests no serious potential ecological concerns. It should be noted however that further studies including the refinement of PEC derivation, identification and toxicity assessment of the metabolites and/or their interactions with other stressors may be warranted to better understand the environmental consequences of the residual pharmaceutical discharge to the waterway.

  • PDF

UV/H2O2 고도산화기술을 이용한 수중 잔류의약물질 제거 (Degradation of residual pharmaceuticals in water by UV/H2O2 advanced oxidation process)

  • 박진영;서상원;조익환;전용성;하현섭;황태문
    • 상하수도학회지
    • /
    • 제33권6호
    • /
    • pp.469-480
    • /
    • 2019
  • This study was conducted to evaluate the degradation and mineralization of PPCPs (Pharmaceuticals and Personal Care Products) using a CBD(Collimated Beam Device) of UV/H2O2 advanced oxidation process. The decomposition rate of each substance was regarded as the first reaction rate to the ultraviolet irradiation dose. The decomposition rate constants for PPCPs were determined by the concentration of hydrogen peroxide and ultraviolet irradiation intensity. If the decomposition rate constant is large, the PPCPs concentration decreases rapidly. According to the decomposition rate constant, chlortetracycline and sulfamethoxazole are expected to be sufficiently removed by UV irradiation only without the addition of hydrogen peroxide. In the case of carbamazepine, however, very high UV dose was required in the absence of hydrogen peroxide. Other PPCPs required an appropriate concentration of hydrogen peroxide and ultraviolet irradiation intensity. The UV dose required to remove 90% of each PPCPs using the degradation rate constant can be calculated according to the concentration of hydrogen peroxide in each sample. Using this reaction rate, the optimum UV dose and hydrogen peroxide concentration for achieving the target removal rate can be obtained by the target PPCPs and water properties. It can be a necessary data to establish design and operating conditions such as UV lamp type, quantity and hydrogen peroxide concentration depending on the residence time for the most economical operation.

Caffeine과 Carbamazepine: 낙동강 수계에서의 검출 및 정수처리 공정에서의 거동 (Caffeine and Carbamazepine: Detection in Nakdong River Basin and Behavior under Drinking Water Treatment Processes)

  • 손희종;염훈식;정종문;장성호;김한수
    • 한국환경과학회지
    • /
    • 제21권7호
    • /
    • pp.837-843
    • /
    • 2012
  • The aims of this study were to investigated the occurrence of caffeine and carbamazepine in Nakdong river basin (8 mainstreams and 2 tributaries) and the behavior of caffeine and carbamazepine under drinking water treatment processes (conventional and advanced processes). The examination results showed that caffeine was detected at all sampling sites (5.4~558.5 ng/L), but carbamazepine was detected at five sampling sites (5.1~79.4 ng/L). The highest concentration level of caffeine and carbamazepine in the mainstream and tributaries in Nakdong river were Goryeong and Jinchun-cheon, respectively. These pharmaceutical products were completely removed when they were subject to conventional plus advanced processes of drinking water treatment processes. Conventional processes of coagulation, sedimentation and sand-filtration were not effective for their removal, while advanced processes of ozonation and biological activated carbon (BAC) filtration were effective. Among these pharmaceuticals, carbamazeoine was more subject to ozonation than caffeine.

Permitted Daily Exposure for Diisopropyl Ether as a Residual Solvent in Pharmaceuticals

  • Romanelli, Luca;Evandri, Maria Grazia
    • Toxicological Research
    • /
    • 제34권2호
    • /
    • pp.111-125
    • /
    • 2018
  • Solvents can be used in the manufacture of medicinal products provided their residual levels in the final product comply with the acceptable limits based on safety data. At worldwide level, these limits are set by the "Guideline Q3C (R6) on impurities: guideline for residual solvents" issued by the ICH. Diisopropyl ether (DIPE) is a widely used solvent but the possibility of using it in the pharmaceutical manufacture is uncertain because the ICH Q3C guideline includes it in the group of solvents for which "no adequate toxicological data on which to base a Permitted Daily Exposure (PDE) was found". We performed a risk assessment of DIPE based on available toxicological data, after carefully assessing their reliability using the Klimisch score approach. We found sufficiently reliable studies investigating subchronic, developmental, neurological toxicity and carcinogenicity in rats and genotoxicity in vitro. Recent studies also investigated a wide array of toxic effects of gasoline/DIPE mixtures as compared to gasoline alone, thus allowing identifying the effects of DIPE itself. These data allowed a comprehensive toxicological evaluation of DIPE. The main target organs of DIPE toxicity were liver and kidney. DIPE was not teratogen and had no genotoxic effects, either in vitro or in vivo. However, it appeared to increase the number of malignant tumors in rats. Therefore, DIPE could be considered as a non-genotoxic animal carcinogen and a PDE of 0.98 mg/day was calculated based on the lowest No Observed Effect Level (NOEL) value of $356mg/m^3$ (corresponding to 49 mg/kg/day) for maternal toxicity in developmental rat toxicity study. In a worst-case scenario, using an exceedingly high daily dose of 10 g/day, allowed DIPE concentration in pharmaceutical substances would be 98 ppm, which is in the range of concentration limits for ICH Q3C guideline class 2 solvents. This result might be considered for regulatory decisions.